Haiying Zhan, MD, PhD
Assistant Professor of PathologyCards
About
Research
Publications
2026
Pathologic characterization of non-mass enhancement lesions of the breast in MRI-guided biopsy.
Jordan T, Liang Y, Colón Cartagena L, Buza N, Krishnamurti U, Zhan H. Pathologic characterization of non-mass enhancement lesions of the breast in MRI-guided biopsy. Hum Pathol 2026, 106220. PMID: 42556743, DOI: 10.1016/j.humpath.2026.106220.Peer-Reviewed Original ResearchHistomorphologic analysis and clinical correlation of atypical apocrine lesions in breast pathology
Podany P, Zhan H, Colón-Cartagena L, Ai D, Du J, Krishnamurti U, Liang Y. Histomorphologic analysis and clinical correlation of atypical apocrine lesions in breast pathology. Human Pathology 2026, 175: 106158. PMID: 42176994, DOI: 10.1016/j.humpath.2026.106158.Peer-Reviewed Original ResearchPathological response to herceptin-containing neoadjuvant therapy in HER2 IHC2+/ISH+ and IHC3+ early-stage invasive ductal carcinoma
Jordan T, Chan N, Rimm D, Zhan H. Pathological response to herceptin-containing neoadjuvant therapy in HER2 IHC2+/ISH+ and IHC3+ early-stage invasive ductal carcinoma. Human Pathology 2026, 173: 106121. PMID: 41985721, DOI: 10.1016/j.humpath.2026.106121.Peer-Reviewed Original ResearchAdultAgedAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorBreast NeoplasmsCarcinoma, Ductal, BreastFemaleHumansImmunohistochemistryIn Situ Hybridization, FluorescenceMiddle AgedNeoadjuvant TherapyNeoplasm StagingNeoplasm, ResidualPathologic Complete ResponseRetrospective StudiesTrastuzumabTreatment OutcomeDiagnosis of Ductal Carcinoma in Situ in Breast Biopsies for a Radiological Mass Lesion: Did We Miss Something?
Theriot J, Zhan H, Colón-Cartagena L, Lotfi P, Krishnamurti U, Liang Y. Diagnosis of Ductal Carcinoma in Situ in Breast Biopsies for a Radiological Mass Lesion: Did We Miss Something? International Journal Of Surgical Pathology 2026, 10668969261436010. PMID: 41944434, DOI: 10.1177/10668969261436010.Peer-Reviewed Original ResearchClinicopathologic Analyses of 34 Cases of High-Grade Serous-Like Carcinoma (HG-SL-Ca) of the Breast
Haw Y, Krings G, Hsiao W, Zhan H, Hou Y, Zhang G, Zhang H, Wei S, Yang W, Laé M, Post M, Liu Y, Shamir E, Rosa M, Siziopikou K, Schnitt S, Chen Y, Li X. Clinicopathologic Analyses of 34 Cases of High-Grade Serous-Like Carcinoma (HG-SL-Ca) of the Breast. The American Journal Of Surgical Pathology 2026, 50: 543-549. PMID: 41735183, DOI: 10.1097/pas.0000000000002516.Peer-Reviewed Original ResearchQuantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score
He M, Chan N, Liu M, Robbins C, Bates K, Benanto J, Colón-Cartagena L, Kahila M, Zhan H, Krishnamurti U, Moutafi M, Yaghoobi V, Liebler D, Fulton R, Rimm D. Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score. Applied Immunohistochemistry & Molecular Morphology 2026, 34: 143-154. PMID: 41709478, PMCID: PMC13143368, DOI: 10.1097/pai.0000000000001311.Peer-Reviewed Original Research
2025
Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast Cancers
Foldi J, Xiong K, Liu M, Robbins C, Chen F, Zhan H, Burela S, Dai J, Karn P, Dugo M, Bianchini G, Lee A, Oesterreich S, Rimm D, Pusztai L. Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast Cancers. JCO Precision Oncology 2025, 9: e2500529. PMID: 41237360, DOI: 10.1200/po-25-00529.Peer-Reviewed Original ResearchInvasive breast carcinoma in a patient with PHTS: a case report
Zhan H, Fischbach N, Lynch M, Liang Y, Krishnamurti U, Cohen P. Invasive breast carcinoma in a patient with PHTS: a case report. Diagnostic Pathology 2025, 20: 120. PMID: 41107919, PMCID: PMC12532417, DOI: 10.1186/s13000-025-01715-1.Peer-Reviewed Original ResearchPredicting the Probability of Residual Axillary Nodal Metastases in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
Khoury T, Zhan H, Huang X, Ghasemi F, Rajack F, Yuan G, Yu H, Theriot J, Bragiel R, Okamoto K, Ali M. Predicting the Probability of Residual Axillary Nodal Metastases in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy. Modern Pathology 2025, 38: 100902. PMID: 41043643, PMCID: PMC12624850, DOI: 10.1016/j.modpat.2025.100902.Peer-Reviewed Original ResearchInterobserver agreement and histologic analysis of atypical ductal hyperplasia bordering on ductal carcinoma in situ: A multi-institutional study
Korie U, Ai D, Podany P, Zhang H, Zhan H, Kahila M, Colon-Cartagena L, Wei S, Sun H, Du J, Krishnamurti U, Liang Y. Interobserver agreement and histologic analysis of atypical ductal hyperplasia bordering on ductal carcinoma in situ: A multi-institutional study. American Journal Of Clinical Pathology 2025, 164: 704-711. PMID: 40994034, DOI: 10.1093/ajcp/aqaf088.Peer-Reviewed Original Research